Regarding "regarding 'Veterans Affairs (VA) Cooperative Study #362'".
Willard
W
Johnson
D000925:Anticoagulants / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D018890:Chemoprevention / Q000379:methods; D002986:Clinical Trials as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D009426:Netherlands; D014481:United States; D014493:United States Department of Veterans Affairs; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin